Serglycin’s role in primary liver cancer: insights into tumor microenvironment and macrophage interaction
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
Background: Serglycin (SRGN) is an important proteoglycan that regulates tumorigenesis, but its role in primary liver cancer (PLC) remains unclear. Methods: We investigated the expression and prognostic potential of SRGN in PLC using bioinformatics analyses. HepG2 cells were transfected with an SRGN over expression vector and their proliferation, migration, invasion, resistance to sorafenib, and angiogenic capacity were examined in vitro . A subcutaneous xenograft tumor model was created using nude mice. SRGN overexpressing hepatoma cells were co-cultured with THP-1 derived macrophages. The expressions of CD80 and CD206, secretory molecules, and the NF-κB and STAT3 signal pathways were examined by flow cytometry, ELISA and western blot, respectively. Transwell migration and invasion were investigated in HepG2 and Huh7 co-cultured with SRGN-promoted macrophages. Results: Single-cell analysis revealed SRGN expression across 17 distinct cell subpopulations, with higher expression in macrophages in tumor tissues compared to those in normal tissues. SRGN displayed consistent high expression across cell cycle phases while exhibited dynamic expression during macrophage pseudotime trajectory. Cell communication analysis indicated that SRGN was involved in interactions within the tumor microenvironment (TME), particularly in the VEGF signaling network. Autocrine SRGN promoted in vitro aggressiveness, especially pro-angiogenic activity, and in vivo tumorigenicity of HepG2 cells, and conferred resistance to sorafenib. Paracrine SRGN promoted a partial polarization of TAMs toward an M2-like phenotype, accompanied by the activation of signaling pathways including NF-κB and STAT3. Levels of secreted argase1 and SRGN were increased in the supernatant. The invasion and migration of hepatoma cells were promoted by SRGN-overexpressing TAMs. Conclusions: Our findings highlight the role of SRGN in the TME of PLC. SRGN-high TAMs are induced by paracrine SRGN from hepatoma cells, establishing a self-reinforcing mechanism that drives PLC progression. Therapeutic strategies targeting SRGN should take into account its context-specific roles depending on TME cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Cohen, J. (2013) · doi:10.4324/9780203771587 · Cited by 25,373
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“Immune microenvironment characterization was performed using single-sample gene set enrichment analysis (ssGSEA) implemented via the GSVA package (34), utilizing 24 gene sets corresponding to immune cell signatures (35).”
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Li, T., Fan, J., Wang, B., Traugh, N., Chen, Q., Liu, J. S., Li, B., & Liu, X. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0307 · Cited by 5,913
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694 · cited 2×
“TIMER analysis suggested that SRGN expression was closely related to TME cells (Supplementary Tables 2, 3), which should be considered in multivariate Cox regression models.”
Pancancer survival analysis of cancer hallmark genes
Nagy, Á., Munkácsy, G., & Győrffy, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-84787-5 · Cited by 1,381
The human protein atlas: a spatial map of the human proteome
Thul, P. J., & Lindskog, C. (2018) · Protein Science · doi:10.1002/pro.3307 · Cited by 1,299
The CPTAC Data Portal: A Resource for Cancer Proteomics Research
Edwards, N. J., Oberti, M., Thangudu, R. R., Cai, S., McGarvey, P. B., Jacob, S., Madhavan, S., & Ketchum, K. A. (2015) · Journal of Proteome Research · doi:10.1021/pr501254j · Cited by 558
Research works printed but not linked: 1
- Li, 2013, Expression of serglycin in HepG2 cells with different HBV infection status
Cited by
Wu, D., Liu, C., Zhan, L., Liang, M., Li, Q., & Lian, Q. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102853 · Cited by 7
“To assign cell identities, we cross ‑ referenced cluster ‑ specific marker genes against known cell ‑ type signatures documented in the original publication [2], ACT database [20 – 23], DeepCellSeek (https://deepcellseek.kiz.ac.cn/) and the Cell-Marker 2.0 repository.”
InfluentialSelf-citationLiu, J., Chen, X., Liu, C., Yang, C., & Li, B. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102722 · Cited by 3
“Through systematic assessment, a clustering resolution of 0.1 was identified as optimal for subsequent visualization and analysis [33].”
InfluentialZhang, M., Zhao, Z., Zhu, Q., Liang, S., Sun, L., Wei, H., Liu, S. S., Zhao, M., Li, L., & Wang, L. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102927 · Cited by 2
Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review
Chen, S., Tu, L., & Chen, Q. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1898418 · Cited by 1
“Lian et al. (Lian et al., 2025) identified the proteoglycan Serglycin as a critical extracellular modulator in primary liver cancer, demonstrating that it shapes an immunosuppressive tumor microenvironment by orchestrating interactions with tumor-associated macrophages.”
AJUBA: The Master Regulator Bridging EMT and Immune Evasion in Colorectal Cancer
Shen, W., Cui, M., Liao, X., Xiong, Y., Zou, B., Zhang, X., & Shao, C. (2026) · Mediators of Inflammation · doi:10.1155/mi/7828477 · Cited by 1
“GAPDH (1:5,000; Proteintech Group, Inc.) served as the internal loading control [31].”
Metadata
- Authors
- Lian, Q., Ma, C., Wang, X., Wang, J., Zeng, J., Zhang, J., & Li, Y.
- Affiliations
- Sun Yat-sen University (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Corresponding author
- Zeng, Jindi
- Zhang, Jiongshan
- Li, Yongwei
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2025-12-16
- Volume
- 16
- Pages
- 1668627-1668627
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC12748857
- OpenAlex
- W4417356273
- Cited by
- 10
- References
- 67
- Citations by year
- 2026: 10
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- Universidade de Macau
- Basic and Applied Basic Research Foundation of Guangdong Province
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- serglycin, primary liver cancer, hepatocellular carcinoma, tumor microenvironment, tumor-associated macrophages, TAM polarization, M2 macrophages, NF-κB signaling, STAT3 signaling, sorafenib resistance, angiogenesis, VEGF signaling, proteoglycans, prognostic factors
- MeSH terms
- Tumor-Associated Macrophages, Animals, Cell Communication, Cell Movement, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Macrophages, Male, Mice, Nude, Proteoglycans, Signal Transduction, Vesicular Transport Proteins, Cell Line, Tumor, Cell Proliferation, Mice, Hep G2 Cells, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serglycin’s role in primary liver cancer: insights into tumor microenvironment and macrophage interaction. https://app.cochat.ai/papers/10.3389/fimmu.2025.1668627
- The paper
- Lian, Q., Ma, C., Wang, X., Wang, J., Zeng, J., Zhang, J., & Li, Y. (2025). Serglycin’s role in primary liver cancer: insights into tumor microenvironment and macrophage interaction. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1668627
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.